Sign in
4

Changes in Ownership

Moleculin Biotech, Inc. Filed Acc 0001437749-22-015665

Options or other derivatives

  • Chief Science Officer acquired 129,667 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
PICKER DONALD H Chief Science Officer 2022-06-20 Grant or award · Stock option (right to buy) +65,000 183,510 D
PICKER DONALD H Chief Science Officer 2022-06-20 Grant or award · Restricted Stock Units +64,667 248,177 D
Loading xslF345X03/rdgdoc.xml…